Megan M. Herr

1.2k total citations
35 papers, 256 citations indexed

About

Megan M. Herr is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Megan M. Herr has authored 35 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 11 papers in Hematology. Recurrent topics in Megan M. Herr's work include Lymphoma Diagnosis and Treatment (11 papers), CAR-T cell therapy research (8 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Megan M. Herr is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), CAR-T cell therapy research (8 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Megan M. Herr collaborates with scholars based in United States, Germany and Israel. Megan M. Herr's co-authors include Paul M. Barr, Margaret A. Tucker, Rochelle E. Curtis, Theresa Hahn, Lindsay M. Morton, George L. Chen, Sara J. Schonfeld, Kristin M. Fries, Philip L. McCarthy and L. George Upton and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Megan M. Herr

32 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan M. Herr United States 9 96 87 57 42 33 35 256
S. Grisanti Italy 8 72 0.8× 56 0.6× 35 0.6× 34 0.8× 20 0.6× 21 213
Michael J. Schwerer Germany 11 84 0.9× 95 1.1× 64 1.1× 46 1.1× 7 0.2× 23 299
Hongfa Yang China 9 54 0.6× 47 0.5× 125 2.2× 26 0.6× 16 0.5× 17 378
Masayuki Aoki Japan 10 58 0.6× 62 0.7× 100 1.8× 9 0.2× 28 0.8× 14 303
Alice Mariottini Italy 12 109 1.1× 174 2.0× 40 0.7× 29 0.7× 39 1.2× 39 325
Atrin Toussi United States 9 66 0.7× 51 0.6× 80 1.4× 11 0.3× 15 0.5× 23 417
Michal Kýr Czechia 11 68 0.7× 27 0.3× 80 1.4× 26 0.6× 9 0.3× 29 284
Ana Jiménez Ubieto Spain 9 95 1.0× 78 0.9× 66 1.2× 50 1.2× 68 2.1× 42 212
Jahanzaib Khwaja United Kingdom 9 32 0.3× 95 1.1× 45 0.8× 99 2.4× 60 1.8× 42 253
Olga Grishina Germany 7 46 0.5× 46 0.5× 53 0.9× 60 1.4× 161 4.9× 16 269

Countries citing papers authored by Megan M. Herr

Since Specialization
Citations

This map shows the geographic impact of Megan M. Herr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan M. Herr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan M. Herr more than expected).

Fields of papers citing papers by Megan M. Herr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan M. Herr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan M. Herr. The network helps show where Megan M. Herr may publish in the future.

Co-authorship network of co-authors of Megan M. Herr

This figure shows the co-authorship network connecting the top 25 collaborators of Megan M. Herr. A scholar is included among the top collaborators of Megan M. Herr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan M. Herr. Megan M. Herr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malek, Ehsan, Grant Schofield, Shernan G. Holtan, et al.. (2024). Influence of Myeloma Cell Expressed CD28 and CD86 on BCMA CAR T Cell Efficacy and Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS). Blood. 144(Supplement 1). 3445–3445.
2.
3.
Singh, Abhay, Nuria Mencia-Trinchant, Elizabeth A. Griffiths, et al.. (2021). DNMT3A and TET2 mutant Clonal Hematopoiesis May Drive a Proinflammatory State and Predict Enhanced Response to Immune Checkpoint Inhibitors. Blood. 138(Supplement 1). 4295–4295. 4 indexed citations
4.
Singh, Abhay, Megan M. Herr, Elizabeth A. Griffiths, et al.. (2021). Emerging trends of therapy related myeloid neoplasms following modern cancer therapeutics in the United States. Scientific Reports. 11(1). 23284–23284. 4 indexed citations
5.
Herr, Megan M., Shabnam Rehman, Yali Zhang, et al.. (2021). Replicated Risk Index of Patient Functional Status Prior to Allogeneic Hematopoietic Cell Transplantation Predicts Healthcare Utilization and Survival. Transplantation and Cellular Therapy. 27(10). 875.e1–875.e9. 1 indexed citations
6.
Herr, Megan M., George L. Chen, Maureen Ross, et al.. (2020). Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell-Associated Encephalopathy (ICE) Score. Biology of Blood and Marrow Transplantation. 26(11). e271–e274. 21 indexed citations
7.
Merz, Maximilian, Yali Zhang, George L. Chen, et al.. (2020). Serological Response to Vaccination after Autologous Transplantation for Multiple Myeloma Is Associated with Improved Progression-Free and Overall Survival. Transplantation and Cellular Therapy. 27(3). 245.e1–245.e8. 3 indexed citations
8.
Brown, Anne Rain, Prabalini Rajendram, Megan M. Herr, et al.. (2020). 482: Chimeric Antigen Receptor (CAR) Cell Patients Admitted to the ICU: The CAR-ICU Initiative Experience. Critical Care Medicine. 49(1). 232–232. 1 indexed citations
9.
Herr, Megan M., Cristina Gutiérrez, Anne Rain Brown, et al.. (2020). 44: Cytokine Release Syndrome in Chimeric Antigen Receptor T-Cell Therapy: The CAR-ICU Experience. Critical Care Medicine. 49(1). 23–23.
10.
Mohammadpour, Hemn, Cameron R. MacDonald, George L. Chen, et al.. (2020). β2-Adrenergic receptor activation on donor cells ameliorates acute GvHD. JCI Insight. 5(12). 14 indexed citations
11.
Merz, Maximilian, Jie Wang, Lei Wei, et al.. (2020). Prospective evaluation of spatial heterogeneity at single cell resolution in multiple myeloma.. Journal of Clinical Oncology. 38(15_suppl). 8524–8524. 2 indexed citations
12.
Herr, Megan M., Rochelle E. Curtis, Margaret A. Tucker, et al.. (2019). Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation. Journal of the American Academy of Dermatology. 83(3). 762–772. 6 indexed citations
13.
Schonfeld, Sara J., Diana M. Merino, Rochelle E. Curtis, et al.. (2019). Risk of Second Primary Bone and Soft–Tissue Sarcomas Among Young Adulthood Cancer Survivors. JNCI Cancer Spectrum. 3(3). pkz043–pkz043. 5 indexed citations
14.
Herr, Megan M., Pallawi Torka, Yali Zhang, et al.. (2019). Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant. Bone Marrow Transplantation. 55(1). 77–85. 3 indexed citations
15.
Herr, Megan M., Sara J. Schonfeld, Graça M. Dores, et al.. (2018). Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival. JNCI Journal of the National Cancer Institute. 110(11). 1248–1258. 17 indexed citations
16.
Hunter, Bradley D., Megan M. Herr, Ferdous M. Barlaskar, et al.. (2016). Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era. Clinical Lymphoma Myeloma & Leukemia. 17(3). 145–151. 9 indexed citations
17.
Herr, Megan M., Nimish Mohile, Paul M. Barr, et al.. (2016). Survival of Secondary Central Nervous System Lymphoma Patients in the Rituximab Era. Clinical Lymphoma Myeloma & Leukemia. 16(9). e123–e127. 6 indexed citations
18.
Herr, Megan M., Paul M. Barr, David Q. Rich, & Nimish Mohile. (2014). Clinical Features, Treatment, and Survival of Secondary Central Nervous System Lymphoma. Blood. 124(21). 5389–5389. 5 indexed citations
19.
Kelly, Jennifer L., Matthew T. Drake, Zachary S. Fredericksen, et al.. (2012). Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes & Control. 23(7). 1017–1029. 35 indexed citations
20.
Herr, Megan M., Kristin M. Fries, L. George Upton, & Laura E. Edsberg. (2010). Potential Biomarkers of Temporomandibular Joint Disorders. Journal of Oral and Maxillofacial Surgery. 69(1). 41–47. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Grisanti Breakdown of academic impact, for papers by Michael J. Schwerer Breakdown of academic impact, for papers by Hongfa Yang Breakdown of academic impact, for papers by Masayuki Aoki Breakdown of academic impact, for papers by Alice Mariottini Breakdown of academic impact, for papers by Atrin Toussi Breakdown of academic impact, for papers by Michal Kýr Breakdown of academic impact, for papers by Ana Jiménez Ubieto Breakdown of academic impact, for papers by Jahanzaib Khwaja Breakdown of academic impact, for papers by Olga Grishina
Rankless by CCL
2026